| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 305 | 177 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -11 | -9 |
| Net decrease in cash, cash equivalents and restricted cash | -31,488 | -22,031 |
| Cash and cash equivalents at beginning of period | 59,049 | - |
| Cash and cash equivalents at end of period | 27,561 | - |
Korro Bio, Inc. (KRRO)
Korro Bio, Inc. (KRRO)